Clostridioides difficile Infection

Clostridioides difficile infection is a toxin-mediated colitis caused by the spore-forming bacterium C. difficile, which proliferates when the normal gut microbiota is disrupted, most often by antibiotics. It ranges from mild diarrhoea to severe pseudomembranous colitis and is a leading cause of healthcare-associated diarrhoea, with a notable tendency to recur.

Definition

Clostridioides difficile infection is a toxin-mediated colonic infection caused by overgrowth of toxigenic C. difficile, typically following disruption of the gut microbiota, and presenting with diarrhoea that can progress to pseudomembranous or fulminant colitis.

Scope

This entry covers C. difficile infection as a clinical entity: the organism and its toxins, the role of microbiota disruption, the spectrum from diarrhoea to fulminant colitis, recurrence, epidemiology, and the evidence summarised in guidelines. It does not provide individualised diagnostic or treatment recommendations such as drug choices or doses.

Core questions

• How does disruption of the gut microbiota allow toxigenic C. difficile to proliferate and cause disease?
• What roles do toxins A and B play in the colitis?
• Why does C. difficile infection tend to recur, and what makes it a healthcare-associated problem?

Key concepts

• Toxigenic C. difficile and toxins A and B
• Spore formation and environmental persistence
• Microbiota disruption (antibiotic-associated)
• Pseudomembranous colitis
• Recurrent infection
• Healthcare-associated transmission
• Faecal microbiota transplantation (as a studied intervention)

Mechanisms

Clostridioides difficile is an anaerobic, spore-forming bacterium whose spores resist many disinfectants and persist in the environment. When antibiotics or other exposures deplete the protective commensal microbiota, ingested or resident spores germinate and toxigenic strains release toxin A (an enterotoxin) and toxin B (a cytotoxin), which disrupt the colonic epithelial cytoskeleton, trigger inflammation, and cause the watery diarrhoea and, in severe cases, the pseudomembranes that define pseudomembranous colitis. Because spores survive treatment and the microbiota recovers slowly, infection commonly recurs, and restoration of a healthy microbiota is the rationale behind faecal microbiota transplantation studied for recurrent disease.

Clinical relevance

C. difficile infection is a major cause of antibiotic-associated and healthcare-associated diarrhoea and can complicate the course of patients with inflammatory bowel disease. Understanding the link between microbiota disruption and toxin-mediated colitis explains why antibiotic stewardship and infection control are central to prevention. This entry is for reference and does not constitute treatment guidance.

Epidemiology

C. difficile is among the most important causes of healthcare-associated diarrhoea, with risk concentrated in people exposed to antibiotics, those who are hospitalised, and older adults; community-associated cases also occur. The emergence of more virulent strains has been associated with increased severity in some settings, as summarised in clinical reviews and guidelines.

Evidence & guidelines

Society guidelines from the IDSA and SHEA (McDonald et al., 2018) and the American College of Gastroenterology (Kelly et al., 2021), together with narrative reviews (Leffler & Lamont, 2015), summarise diagnosis, severity assessment, and management in a reference framework. This entry provides orientation rather than prescriptive care.

History

Although pseudomembranous colitis was described long before its cause was known, C. difficile was identified as the toxin-producing agent of antibiotic-associated colitis in the late 1970s. Subsequent decades brought recognition of recurrent disease, the emergence of hypervirulent strains, and the study of microbiota-restoring therapies, as synthesised in modern reviews (Leffler & Lamont, 2015).

Debates

How should colonisation be distinguished from true infection in testing?

Because asymptomatic carriage of toxigenic C. difficile is common, the choice and interpretation of diagnostic tests (for example, nucleic acid amplification versus toxin assays) is debated, since over-testing can lead to over-diagnosis and unnecessary treatment.

Seminal works

• leffler-lamont-2015
• mcdonald-2018

Frequently asked questions

Why is C. difficile infection linked to antibiotics?

Antibiotics can deplete the protective gut microbiota, allowing toxigenic C. difficile to proliferate and release toxins that cause colitis; this is why the infection is often described as antibiotic-associated.

Why does C. difficile infection often come back?

The organism forms hardy spores that survive treatment and the environment, and the microbiota recovers slowly, so a substantial fraction of patients experience recurrence; this entry is educational and not a source of treatment advice.